Immunological Abnormalities Associated with liver Disease: Cause or Effect? (Q40532204)

21 September 2017

Immunological abnormalities associated with liver disease: cause or effect? (English)

1 reference

21 September 2017

Immunological Abnormalities Associated with liver Disease: Cause or Effect? (English)

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB02316.X

15 February 2023

1 reference

cell-mediated immunity

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A274938

15 February 2023

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB02316.X

15 February 2023

author name string

C. I. Smith

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A274938

15 February 2023

W. G. Cooksley

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A274938

15 February 2023

L. W. Powell

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A274938

15 February 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=274938

15 February 2023

publication date

1 December 1977

1 reference

full work available at URL

21 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1445-5994.1977.tb02316.x

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB02316.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1445-5994.1977.tb02316.x/fullpdf

15 February 2023

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB02316.X

Australian and New Zealand journal of medicine

15 February 2023

published in

1 reference

21 September 2017

7

1 reference

21 September 2017

6

1 reference

21 September 2017

604-612

1 reference

Immunologic aspects of liver disease

21 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1977.TB02316.X

Genes, viruses, and the immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1977.TB02316.X

Multisystem involvement in chronic liver disease. Studies on the incidence and pathogenesis

21 January 2018

1

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB02316.X

Lupoid hepatitis and the hepatic lesions of systemic lupus erythematosus

15 February 2023

2

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB02316.X

The immunology of liver disease

15 February 2023

3

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB02316.X

15 February 2023

γ-GLOBULIN METABOLISM

6

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB02316.X

SEROLOGICAL ABNORMALITIES IN PATIENTS WITH LIVER DISEASE

15 February 2023

9

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB02316.X

Tissue antibodies in primary biliary cirrhosis, active chronic (lupoid) hepatitis, cryptogenic cirrhosis and other liver diseases and their clinical implications

15 February 2023

10

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB02316.X

SEROLOGICAL TESTS IN DIAGNOSIS OF PRIMARY BILIARY CIRRHOSIS

15 February 2023

11

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB02316.X

Antibody to smooth muscle in patients with liver disease

15 February 2023

12

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB02316.X

Autoantibodies and the Hepatitis-associated Antigen in Acute Infective Hepatitis

15 February 2023

15

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB02316.X

Smooth muscle autoantibodies in infectious mononucleosis

15 February 2023

16

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB02316.X

Mitochondrial antibodies and subclinical liver disease

15 February 2023

17

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB02316.X

Antibodies to cytoplasmic antigens in primary biliary cirrhosis and chronic active hepatitis

15 February 2023

19

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB02316.X

Immunologic Studies in Patients with Chronic Active Hepatitis and Primary Biliary Cirrhosis I. Cytotoxic Activity and Binding of Sera to Human Liver Cells Grown in Tissue Culture

15 February 2023

21

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB02316.X

Mitochondrial antibodies (AMA)

15 February 2023

22

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB02316.X

Experimental smooth muscle antibodies

15 February 2023

24

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB02316.X

15 February 2023

Lupoid hepatitis

25

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB02316.X

An autoimmune reaction against human tissue antigens in certain acute and chronic diseases. I. Serological investigations

15 February 2023

26

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB02316.X

An autoimmune reaction against human tissue antigens in certain acute and chronic diseases. II. Clinical correlations

15 February 2023

27

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB02316.X

The pathogenesis of alcoholic hepatitis and cirrhosis

15 February 2023

28

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB02316.X

Occurrence of complement-fixing antibodies reactive with normal tissue constituents in normal and disease states

15 February 2023

29

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB02316.X

Complement fixing reactions with liver tissue in human disease

15 February 2023

30

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB02316.X

Detection of a Liver-Membrane Autoantibody in HBsAg-negative Chronic Active Hepatitis

15 February 2023

35

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB02316.X

IMMUNOCYTOCHEMICAL AND SEROLOGIC OBSERVATIONS IN PRIMARY BILIARY CIRRHOSIS

15 February 2023

36

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB02316.X

The Presentation and Diagnosis of 100 Patients with Primary Biliary Cirrhosis

15 February 2023

41

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB02316.X

Experimental chronic active hepatitis in rabbits following immunization with human liver proteins

15 February 2023

42

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB02316.X

Studies on the pathogenesis of experimental chronic active hepatitis in rabbits. I. Induction of the disease and protective effect of allogeneic liver specific proteins

15 February 2023

43

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB02316.X

Controlled study of autoimmunization against liver in inbred rat strains

15 February 2023

44

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB02316.X

Studies concerning the importance of mononuclear cells in the development of experimental hepatitis

15 February 2023

45

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB02316.X

Immunological studies on the development of experimental hepatitis in thymectomized mice

15 February 2023

46

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB02316.X

Thymus-dependent lymphocyte function in patients with hepatitis-associated antigen

15 February 2023

51

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB02316.X

Impaired delayed hypersensitivity in primary biliary cirrhosis.

15 February 2023

52

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB02316.X

Immune reactions in acute viral hepatitis

15 February 2023

53

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB02316.X

Cell-mediated immunity in acute and chronic hepatitis

15 February 2023

54

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB02316.X

Reduction in circulating T lymphocytes in alcoholic liver disease

15 February 2023

55

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB02316.X

Lymphocyte stimulation and chronic liver disease

15 February 2023

56

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB02316.X

Cell-mediated immune reactivity in liver disease

15 February 2023

58

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB02316.X

Cell-mediated Immune Responses in Chronic Liver Diseases

15 February 2023

60

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB02316.X

Cell-mediated immunity to a human liver-specific antigen in patients with active chronic hepatitis and primary biliary cirrhosis.

15 February 2023

62

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB02316.X

Organ-specificity and diagnostic value of cell-mediated immunity against a liver-specific membrane protein: studies in hepatic and non-hepatic diseases

15 February 2023

64

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB02316.X

Lymphocyte cytotoxicity to isolated hepatocytes in chronic active hepatitis

15 February 2023

65

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB02316.X

Antibody-dependent cell-mediated (K cell) cytotoxicity against isolated hepatocytes in chronic active hepatitis

15 February 2023

66

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB02316.X

Cell-mediated immunity to liver in patients with alcoholic hepatitis

15 February 2023

71

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB02316.X

Immunological Abnormalities Associated with liver Disease: Cause or Effect?

15 February 2023

72

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB02316.X

Inadequate antibody response to hBAg or suppressor T-cell defect in development of active chronic hepatitis.

15 February 2023

76

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB02316.X

Drug-induced active chronic hepatitis

15 February 2023

78

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB02316.X

Chronic active and lupoid hepatitis caused by a laxative, oxyphenisatin.

15 February 2023

79

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB02316.X

Chronic hepatitis as a first manifestation of Wilson's disease

15 February 2023

80

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB02316.X

Immunological Changes and Liver Disease Associated with α1-Antitrypsin Deficiency

15 February 2023

81

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB02316.X

Hepatitis-associated Antigen and Antibody in Haemodialysis Patients and Staff

15 February 2023

88

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB02316.X

Australia antigen as a hepatitis virus. Variation in host response

15 February 2023

90

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB02316.X

A serum antigen (Australia antigen) in Down's syndrome, leukemia, and hepatitis

15 February 2023

92

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB02316.X

Association between lepromatous leprosy and Australia antigen

15 February 2023

93

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB02316.X

Thymus-dependent lymphocyte function in patients with hepatitis-associated antigen

15 February 2023

94

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB02316.X

Liver disease and cell-mediated immunity in hepatitis-associated antigen (HAA) carriers

15 February 2023

95

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB02316.X

Specific lymphocyte stimulation by purified, heat-inactivated hepatitis-B antigen.

15 February 2023

98

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB02316.X

Chronic Hepatitis — Migration Inhibition of Leukocytes in the Presence of Australia Antigen

15 February 2023

100

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB02316.X

Cell-mediated Immunity in Patients Positive for Hepatitis-associated Antigen

15 February 2023

101

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB02316.X

Cell-mediated immune response to hepatitis B antigen in patients with liver disease.

15 February 2023

104

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB02316.X

The role of immunological mechanisms in acute and chronic hepatitis

15 February 2023

108

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB02316.X

Immunodeficiency to hepatitis B virus infection and genetic susceptibility to development of hepatocellular carcinoma

15 February 2023

109

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB02316.X

Histocompatibility-linked immune response genes

15 February 2023

111

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB02316.X

Genetic analysis of patients with chronic active hepatitis

15 February 2023

112

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB02316.X

Association of autoimmune active chronic hepatitis with HL-A1,8.

15 February 2023

113

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB02316.X

Histocompatibility antigens in active chronic hepatitis and primary biliary cirrhosis.

15 February 2023

114

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB02316.X

15 February 2023

Identifiers

1 reference

21 September 2017

1 reference